PDS Announces Expanded Licensing Options for the Web-Based, Hosted Applicaton Choices
News Jun 14, 2006
PDS Pathology Data Systems Ltd. has announced additional licensing options to meet wider needs of University research departments, CROs, Biotechs and smaller Toxicology and Pathology work groups and for customers that wish to use this software in a hosted and administration-free environment via the Internet.
"The enthusiasm with which our hosted options have been embraced is gratifying," said Arthur Karakos, CEO of the vendor’s North America marketing and support group, Pathology Data Solutions Inc.
"Not only are research universities and CROs enthused about being able to utilize the same powerful and flexible mission-critical software that is used by 7 of the 10 Top-Ten Pharma companies but, interestingly enough, so are biotech companies."
He went on to say, "They see the value of being able to use the exact same software solutions as many of the world’s finest pharmaceutical companies and CROs, but without the upfront costs - plus they really like their ability to simply pay-as-they-go without impacting their capital budgets."
The PathData System is designed to offer users a complete array of post-mortem functionalities - from necropsy and histology to microscopy, statistics, tables, peer review, imaging and FDA-compliant final report generation.
The ante-mortem aspects are covered by the company’s ToxData System for toxicology and clinical pathology and the ReproData System for comprehensive reproductive toxicology and teratology.
All three systems are tightly integrated and form the foundation of the PDS Preclinical Suite of products.
The systems are modular and scalable to grow with the users, so they are an option for the entire range of customers- from single users to global, multi-site organizations.
Differentiated from its competitors, PDS software solutions are neither operating system nor database-version dependent.
In addition, the systems do not require any third-party products for statistical analysis, word processing or image capturing in order to function.
All integrated statistics, imaging and reporting options are handled efficiently without the need to master additional software or rely on questionable external software life cycles that can cause havoc in a validated environment.
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal TrialsNews
A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019